Corcept Therapeutics, Inc. (CORT)
37.00
+1.22
(+3.41%)
USD |
NASDAQ |
Jan 07, 16:00
36.94
-0.06
(-0.16%)
After-Hours: 05:41
Corcept Therapeutics Research and Development Expense (Quarterly): 68.85M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Axsome Therapeutics, Inc. | 40.04M |
| Johnson & Johnson | 3.693B |
| United Therapeutics Corp. | 127.50M |
| Vertex Pharmaceuticals, Inc. | 977.70M |
| Theravance Biopharma, Inc. | 7.707M |